Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 13/20 | 0.64 |
| ▸ | NT5C2 | P49902 | 2/20 | 0.59 |
| ▸ | NT5E | P21589 | 1/20 | 0.57 |
| ▸ | KDR | P35968 | 2/20 | 0.55 |
| ▸ | TP53 | P04637 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.55 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1898390 | 0.81 | RAB9A (0.51) | TP53MEN1CYP1A2TSHRKMT2A | |
| SCHEMBL23124 | 0.79 | BRD4 (1.00) | BRD4NT5C2NT5ECREBBPRAB9A | |
| SCHEMBL29514799 | 0.79 | BRD4 (1.00) | BRD4NT5C2NT5ECREBBPRAB9A | |
| SCHEMBL8381776 | 0.77 | BRD4 (0.97) | BRD4NT5C2NT5ECREBBPRAB9A | |
| SCHEMBL9801799 | 0.77 | SMN1; SMN2 (0.61) | BRD4KDRTP53MEN1CYP1A2 | |
| SCHEMBL6463477 | 0.75 | BRD4 (0.92) | BRD4NT5C2NT5ECREBBP | |
| SCHEMBL38666421 | 0.75 | BRD4 (0.66) | BRD4NT5C2NT5ETP53MEN1 | |
| SCHEMBL22118772 | 0.74 | BRD4 (0.68) | BRD4NT5C2NT5ETP53CYP1A2 | |
| Kinetin SCHEMBL15941491 | 0.73 | SMN1; SMN2 (0.86) | BRD4KDRTP53MEN1CYP1A2 | |
| SCHEMBL5437612 | 0.73 | BRD4 (0.62) | BRD4NT5C2NT5ETP53CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1901817-A2 | PERSONAL CARE COMPOSITIONS AND METHODS FOR THE BEAUTIFICATION OF MAMMALIAN SKIN AND HAIR | The Procter and Gamble Company (US) | 2008-03-26 | — | — | EP | claimed |
| WO-2007007255-A2 | PERSONAL CARE COMPOSITIONS AND METHODS FOR THE BEAUTIFICATION OF MAMMALIAN SKIN AND HAIR | THE PROCTER & GAMBLE COMPANY (US) | 2007-01-18 | — | — | WO | claimed |
| US-20070009474-A1 | Personal care compositions and methods for the beautification of mammalian skin and hair | THE PROCTER & GAMBLE COMPANY | 2007-01-11 | — | — | US | claimed |
| EP-2498772-B1 | COMPOSITION AND METHODS FOR IMPROVING SKIN APPEARANCE | SYTHEON LTD (US) | 2025-07-30 | — | — | EP | disclosed |
| US-8496917-B2 | Compositions and methods for improving skin appearance | SYTHEON LTD (US) | 2013-07-30 | — | — | US | disclosed |
| US-20130183257-A1 | COMPOSITIONS AND METHODS FOR IMPROVING SKIN APPEARANCE | SYTHEON LTD. (US) | 2013-07-18 | — | — | US | disclosed |
| EP-2498772-A2 | COMPOSITION AND METHODS FOR IMPROVING SKIN APPEARANCE | Sytheon Ltd. (US) | 2012-09-19 | — | — | EP | disclosed |
| US-20110117036-A1 | Compositions and Methods for Improving Skin Appearance | SYTHEON LIMITED (US) | 2011-05-19 | — | — | US | disclosed |
| WO-2011059866-A2 | COMPOSITION AND METHODS FOR IMPROVING SKIN APPEARANCE | SYTHEON LTD. (US) | 2011-05-19 | — | — | WO | disclosed |
| US-20080076720-A1 | Personal care compositions having kinetin or zeatin | THE PROCTER & GAMBLE COMPANY | 2008-03-27 | — | — | US | disclosed |
| EP-1901817-A2 | PERSONAL CARE COMPOSITIONS AND METHODS FOR THE BEAUTIFICATION OF MAMMALIAN SKIN AND HAIR | The Procter and Gamble Company (US) | 2008-03-26 | — | — | EP | disclosed |
| EP-1901817-A2 | PERSONAL CARE COMPOSITIONS AND METHODS FOR THE BEAUTIFICATION OF MAMMALIAN SKIN AND HAIR | The Procter and Gamble Company (US) | 2008-03-26 | — | — | EP | disclosed |
| WO-2007007255-A3 | PERSONAL CARE COMPOSITIONS AND METHODS FOR THE BEAUTIFICATION OF MAMMALIAN SKIN AND HAIR | PROCTER & GAMBLE (US) | 2007-03-29 | — | — | WO | disclosed |
| WO-2007007255-A2 | PERSONAL CARE COMPOSITIONS AND METHODS FOR THE BEAUTIFICATION OF MAMMALIAN SKIN AND HAIR | THE PROCTER & GAMBLE COMPANY (US) | 2007-01-18 | — | — | WO | disclosed |
| WO-2007007255-A2 | PERSONAL CARE COMPOSITIONS AND METHODS FOR THE BEAUTIFICATION OF MAMMALIAN SKIN AND HAIR | THE PROCTER & GAMBLE COMPANY (US) | 2007-01-18 | — | — | WO | disclosed |
| US-20070009474-A1 | Personal care compositions and methods for the beautification of mammalian skin and hair | THE PROCTER & GAMBLE COMPANY | 2007-01-11 | — | — | US | disclosed |
| US-20070009474-A1 | Personal care compositions and methods for the beautification of mammalian skin and hair | THE PROCTER & GAMBLE COMPANY | 2007-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110117036-A1 | Compositions and Methods for Improving Skin Appearance | CUTA, C5, C1S | BRD4 4380/4885NT5C2 2549/4885NT5E 1637/4885 |
| US-20130183257-A1 | COMPOSITIONS AND METHODS FOR IMPROVING SKIN APPEARANCE | CUTA, C5, C1S | BRD4 4380/4885NT5C2 2549/4885NT5E 1637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.